Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNA7 | P36544 | 9/20 | 0.75 |
| ▸ | PTGS2 | P35354 | 6/20 | 0.72 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.67 |
| ▸ | CA9 | Q16790 | 3/20 | 0.63 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.62 |
| ▸ | CA1 | P00915 | 1/20 | 0.59 |
| ▸ | CA2 | P00918 | 1/20 | 0.59 |
| ▸ | CA4 | P22748 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8423687 | 0.91 | PTGS2 (0.66) | CHRNA7PTGS2PTGS1CA9SMN1; SMN2 | |
| SCHEMBL8423136 | 0.91 | CHRNA7 (0.68) | CHRNA7PTGS2PTGS1CA9SMN1; SMN2 | |
| SCHEMBL8126719 | 0.89 | PTGS2 (0.74) | CHRNA7PTGS2PTGS1SMN1; SMN2 | |
| SCHEMBL8119702 | 0.89 | PTGS2 (0.74) | CHRNA7PTGS2PTGS1SMN1; SMN2 | |
| SCHEMBL6342008 | 0.86 | CHRNA7 (1.00) | CHRNA7PTGS2CA9SMN1; SMN2 | |
| SCHEMBL8126788 | 0.85 | PTGS2 (0.74) | CHRNA7PTGS2PTGS1SMN1; SMN2 | |
| SCHEMBL8122672 | 0.85 | PTGS2 (0.74) | CHRNA7PTGS2PTGS1SMN1; SMN2 | |
| SCHEMBL5698697 | 0.84 | PTGS2 (0.88) | CHRNA7PTGS2PTGS1SMN1; SMN2 | |
| SCHEMBL212983 | 0.83 | PTGS2 (0.83) | CHRNA7PTGS2PTGS1CA9CA1 | |
| SCHEMBL8121503 | 0.83 | PTGS2 (0.83) | CHRNA7PTGS2PTGS1CA9CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0731796-B1 | 1,3,5-TRISUBSTITUTED PYRAZOLE COMPOUNDS FOR TREATMENT OF INFLAMMATION | SEARLE & CO (US) | 2000-08-02 | — | — | EP | claimed |
| EP-0731796-A1 | 1,3,5-TRISUBSTITUTED PYRAZOLE COMPOUNDS FOR TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1996-09-18 | — | — | EP | claimed |
| WO-1995015318-A1 | 1,3,5-TRISUBSTITUTED PYRAZOLE COMPOUNDS FOR TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1995-06-08 | — | — | WO | claimed |
| US-5908852-A | 1,3,5 trisubstituted pyrazole compounds for treatment of inflammation | G. D. SEARLE & CO. (US) | 1999-06-01 | — | — | US | disclosed |
| US-5434178-A | 1,3,5 trisubstituted pyrazole compounds for treatment of inflammation | G.D. SEARLE & CO. (US) | 1995-07-18 | — | — | US | disclosed |